Drug safety

Macleods recalls combination blood-pressure tablets over dissolution failures

The FDA lists an ongoing Class II nationwide recall of Macleods’ tablets after they failed dissolution specifications.

Reported by 1 outlet Saturday, November 14, 2026

Orange prescription bottles and pills
Photo: CC0

Macleods Pharma USA is recalling olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets after the products failed dissolution specifications, according to FDA recall records. The FDA classified the recall as Class II and listed its status as ongoing. The products were distributed nationwide.

The recall covers Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg. They were sold in 30-count bottles, NDC 33342-246-07, and 90-count bottles, NDC 33342-246-10. The records say the recall started 2026-10-07 and was reported 2026-11-04. The product is marked Rx Only and was manufactured for Macleods Pharma USA, Inc. in Princeton, NJ, and by Macleods Pharmaceuticals Ltd in Daman, India.

Reporting on this story

More top stories

This Week in Medicine

The week in medicine, in five minutes

The most important medical news of the week, summarized for you and easy to read. Every Sunday, free.

Free. No spam. Unsubscribe anytime.